INVA
Innoviva, Inc.
$22.33
-0.84%
$1.6B
No data for this timeframe.
Vol
Market Cap$1.6B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (82%)
Inst. Holders9 funds
Inst. Value$340.7M
Inst. Activity3 buys / 0 sells
Reddit Sentiment67° Warm
SEC Reports3
Recent Activity
May 22, 2026
short_volume
Short Volume: INVA — 82.1% short (0.6M / 0.7M)
Short: 589,297 | Exempt: 223,800 | TRF Vol: 717,911 | Short Ratio: 82.1% | Off-exchange volume (dark
May 20, 2026
Insider
Raifeld Pavel sold 1,130 shares
Chief Executive Officer @ $22.24 ($25.1K)
May 20, 2026
Insider
Zhen Marianne sold 1,127 shares
Chief Accounting Officer @ $22.24 ($25.1K)
May 20, 2026
Insider
Basso Stephen sold 559 shares
Chief Financial Officer @ $22.24 ($12.4K)
May 18, 2026
SEC
Innoviva reported the resignations of board members Derek Small and Mark DiPaolo to focus on their roles at Syndeio BioS
8-K — Impact 3/10
May 6, 2026
SEC
Innoviva reported Q1 2026 total revenue of $98.0M (+11% YoY, slightly below $101.6M consensus) and diluted EPS of $2.22,
8-K — Impact 5/10
Mar 27, 2026
SEC
Innoviva, Inc. filed an amended 10-K to include the audited consolidated financial statements of its majority-owned subs
10-K/A — Impact 3/10
Inst.
TWO SIGMA INVESTMENTS, LP — ADD
839,865 shares ($16.8M)
Price Targets
$35.50
+57.5% upside
Strong Buy
Current $22.54
Low $18.00
Median $39.00
High $46.00
4 analysts
$18.00
$46.00
Analyst Ratings
4Strong Buy
5Buy
1Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 1, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| May 26, 2026 | BTIG | REITERATE | Buy → Buy |
| May 7, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Feb 26, 2026 | BTIG | REITERATE | Buy → Buy |
| Feb 17, 2026 | BTIG | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.50 | $0.50 — $0.50 | 1 | |
| Next Q | $0.46 | $0.46 — $0.46 | 20% YoY | 1 |
| Current FY | $1.91 | $1.91 — $1.91 | 2% YoY | 1 |
| Next FY | $2.21 ▼ -3.3% | $2.21 — $2.21 | 16% YoY | 1 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $158.3M | — |
| RENAISSANCE TECHNOLOGIES LLC | $84.2M | — |
| BANK OF AMERICA CORP | $30.4M | — |
| MORGAN STANLEY | $28.4M | ADD |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $20.4M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Raifeld Pavel | F | $25.1K |
| May 20, 2026 | Zhen Marianne | F | $25.1K |
| May 20, 2026 | Basso Stephen | F | $12.4K |
| May 18, 2026 | Linden Josephine | A | $0.00 |
| May 18, 2026 | Linden Josephine | A | $0.00 |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
9 institutional holders with $340.7M total value (17,045,966 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, BANK. Net buying activity: 3 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 7,917,103 | $158.3M | 46.4% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 4,210,172 | $84.2M | 24.7% | — |
| 3 | BANK OF AMERICA CORP /DE/ | 1,519,203 | $30.4M | 8.9% | — |
| 4 | MORGAN STANLEY | 1,418,739 | $28.4M | 8.3% | ADD +50.6% |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,021,146 | $20.4M | 6.0% | NEW |
| 6 | TWO SIGMA INVESTMENTS, LP | 839,865 | $16.8M | 4.9% | ADD +60.8% |
| 7 | WELLS FARGO & COMPANY/MN | 70,238 | $1.4M | 0.4% | ADD +71.4% |
| 8 | FMR LLC | 29,032 | $580.3K | 0.2% | DOUBLED +163.0% |
| 9 | NORGES BANK | 20,468 | $409.2K | 0.1% | NEW |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | ADD | 522,242 | 839,865 | +60.8% | $16.8M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 40,970 | 70,238 | +71.4% | $1.4M | 2025-Q4 |
| NORGES BANK | NEW | — | 20,468 | — | $409.2K | 2025-Q4 |
| UBS Group AG | DOUBLED | 251,869 | 572,368 | +127.2% | $10.4M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 331,886 | 522,242 | +57.4% | $9.5M | 2025-Q3 |
| NORGES BANK | EXIT | 68,865 | 0 | -100.0% | $0.00 | 2025-Q3 |
| MORGAN STANLEY | ADD | 1,081,658 | 1,629,205 | +50.6% | $32.7M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 667,585 | 331,886 | -50.3% | $6.7M | 2025-Q2 |
| UBS Group AG | TRIM | 545,309 | 251,869 | -53.8% | $5.1M | 2025-Q2 |
| NORGES BANK | NEW | — | 68,865 | — | $1.4M | 2025-Q2 |
| FMR LLC | DOUBLED | 13,196 | 34,703 | +163.0% | $697.2K | 2025-Q2 |
| CITADEL ADVISORS LLC | DOUBLED | 328,416 | 728,455 | +121.8% | $13.2M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 262,739 | 667,585 | +154.1% | $12.1M | 2025-Q1 |
| FMR LLC | TRIM | 44,623 | 13,196 | -70.4% | $239.2K | 2025-Q1 |
| NORGES BANK | EXIT | 85,282 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 308,346 | 676,469 | +119.4% | $11.7M | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 502,355 | 328,416 | -34.6% | $5.7M | 2024-Q4 |
| NORGES BANK | TRIM | 210,009 | 85,282 | -59.4% | $1.5M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 26,385 | 37,022 | +40.3% | $642.3K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 732,296 | — | $14.1M | 2024-Q3 |
8 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Raifeld Pavel | Chief Executive Officer | F | 1,130 | $22.24 | $25.1K |
| May 20, 2026 | Zhen Marianne | Chief Accounting Officer | F | 1,127 | $22.24 | $25.1K |
| May 20, 2026 | Basso Stephen | Chief Financial Officer | F | 559 | $22.24 | $12.4K |
| May 18, 2026 | Linden Josephine | Director | A | 5,733 | $0.00 | $0.00 |
| May 18, 2026 | Linden Josephine | Director | A | 9,166 | $0.00 | $0.00 |
| May 15, 2026 | Raifeld Pavel | Chief Executive Officer | A | 1,123 | $0.00 | $0.00 |
| May 15, 2026 | Basso Stephen | Chief Financial Officer | A | 1,123 | $0.00 | $0.00 |
| May 4, 2026 | DiPaolo Mark | Director | A | 9,786 | $0.00 | $0.00 |
| May 4, 2026 | Haimovitz Jules | Director | A | 9,786 | $0.00 | $0.00 |
| May 4, 2026 | Small Derek A | Director | A | 10,000 | $0.00 | $0.00 |
| May 4, 2026 | Basso Stephen | Chief Financial Officer | A | 93,750 | $0.00 | $0.00 |
| May 4, 2026 | Schlesinger Sarah J. | Director | A | 10,000 | $0.00 | $0.00 |
| May 4, 2026 | Zhen Marianne | Chief Accounting Officer | A | 31,500 | $0.00 | $0.00 |
| May 4, 2026 | Raifeld Pavel | Chief Executive Officer | A | 312,500 | $0.00 | $0.00 |
| May 4, 2026 | DiPaolo Mark | Director | A | 10,000 | $0.00 | $0.00 |
| May 4, 2026 | Haimovitz Jules | Director | A | 10,000 | $0.00 | $0.00 |
| May 4, 2026 | Zhen Marianne | Chief Accounting Officer | A | 12,766 | $0.00 | $0.00 |
| May 4, 2026 | Raifeld Pavel | Chief Executive Officer | A | 126,646 | $0.00 | $0.00 |
| May 4, 2026 | Small Derek A | Director | A | 9,786 | $0.00 | $0.00 |
| May 4, 2026 | Basso Stephen | Chief Financial Officer | A | 37,994 | $0.00 | $0.00 |
| May 4, 2026 | Schlesinger Sarah J. | Director | A | 9,786 | $0.00 | $0.00 |
| Feb 20, 2026 | Raifeld Pavel | Chief Executive Officer | F | 2,986 | $23.39 | $69.8K |
| Feb 20, 2026 | Basso Stephen | Chief Financial Officer | F | 1,244 | $23.39 | $29.1K |
| Feb 20, 2026 | Zhen Marianne | Chief Accounting Officer | F | 2,460 | $23.39 | $57.5K |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 2 neutral. Avg impact: 3.7/10.
NEUTRAL
8-K
3/10
Innoviva reported the resignations of board members Derek Small and Mark DiPaolo to focus on their r
May 18, 2026
MIXED
8-K
5/10
Innoviva reported Q1 2026 total revenue of $98.0M (+11% YoY, slightly below $101.6M consensus) and d
May 6, 2026
NEUTRAL
10-K/A
3/10
Innoviva, Inc. filed an amended 10-K to include the audited consolidated financial statements of its
Mar 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (82% buy). Based on 11 analysts: 4 strong buy, 5 buy, 1 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$35.50 mean target
+57.5% upside
Strong Buy (2.00)
$18.00 Low
$46.00 High
| Metric | Value |
|---|---|
| Current Price | $22.54 |
| Target Low | $18.00 |
| Target Mean | $35.50 |
| Target Median | $39.00 |
| Target High | $46.00 |
| # Analysts | 4 |
| Recommendation | Strong Buy (2.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.50 | $0.50 | $0.50 | — | +0.0% | 1↑ 1↓ | $0.1B | 10.7% | 1 |
| Next Q 2026-09-30 |
$0.46 | $0.46 | $0.46 | 19.6% | +0.0% | 0↑ 1↓ | $0.1B | 5.3% | 1 |
| Current FY 2026-12-31 |
$1.91 | $1.91 | $1.91 | 1.9% | +0.0% | 1↑ 1↓ | $0.4B | 7.1% | 1 |
| Next FY 2027-12-31 |
$2.21 | $2.21 | $2.21 | 15.7% | -3.3% | 0↑ 2↓ | $0.5B | 10.3% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.500 | |
| 7d ago | $0.500 | |
| 30d ago | $0.500 | |
| 60d ago | $0.500 | |
| 90d ago | $0.535 | -0.035 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 1, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 26, 2026 | BTIG | REITERATE | Buy | Buy |
| May 7, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | BTIG | REITERATE | Buy | Buy |
| Feb 17, 2026 | BTIG | INITIATE | — | Buy |
| Dec 16, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 5 | 1 | 1 | 0 | 82% | |
| May 1, 2026 | 4 | 5 | 1 | 1 | 0 | 82% | |
| Apr 1, 2026 | 4 | 5 | 1 | 1 | 0 | 82% | |
| Mar 1, 2026 | 4 | 5 | 1 | 1 | 0 | 82% | |
| Feb 1, 2026 | 3 | 5 | 1 | 1 | 0 | 80% | |
| Jan 1, 2026 | 3 | 5 | 1 | 1 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 22, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 22, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
May 22, 2026
short_volume
Short Volume: INVA — 82.1% short (0.6M / 0.7M)
Short: 589,297 | Exempt: 223,800 | TRF Vol: 717,911 | Short Ratio: 82.1% | Off-exchange volume (dark pool + OTC)
May 13, 2026
earnings_calendar
INVA Q1 2026 Earnings Scheduled — 2026-05-13
May 5, 2026
earnings_calendar
INVA Q1 2026 Earnings Scheduled — 2026-05-05
Mar 4, 2026
earnings_calendar
INVA Q4 2025 Earnings After Market Close — 2026-03-04
Dec 15, 2025
fda_pdufa
PDUFA: INVA — zoliflodacin in uncomplicated gonorrhea in adults and pediatric patients 12 years and older — 2025-12-15
FDA target action date 2025-12-15 for INVA (Innoviva, Inc.). Drug: zoliflodacin. Indication: uncomplicated gonorrhea in adults and pediatric patients